New Delhi, June 9 -- Shares of Balaxi Pharmaceuticals surged over 10 percent on Monday, June 9, after the company announced its strategic expansion roadmap along with its financial results for the fourth quarter and full year of FY25. The small-cap stock, which trades below Rs.100, jumped as much as 10.7 percent in intra-day trade to reach a high of Rs.57.5. The rally came on the back of Balaxi's aggressive plans to enter new markets, strengthen its supply chain through backward integration, and capitalize on its existing presence in frontier markets.

Balaxi outlined an ambitious growth strategy aimed at deepening its presence in current markets and entering new geographies. Between 2021 and 2024, the company expanded into regions such a...